XTL Biopharmaceuticals Ltd. EV/EBITDA 2011-2026 | XTLB

EV/EBITDA Jährlich XTL Biopharmaceuticals Ltd.

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-1.03 K	-11.4	-12.7	-2.03	-6.05	-3.63	-6.83	-10.4	-17.4	-26.5	-32.6

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert	Mindestwert	Durchschnitt
-2.03	-1.03 K	-106

EV/EBITDA anderer Aktien in der Pharmaeinzelhändler

Name	EV/EBITDA	Preis	% 24h	Marktkapitalisierung	Land
MorphoSys AG MOR	-0.591	-	2.43 %	$ 254 M	Germany
Altimmune ALT	-1.66	$ 3.47	3.89 %	$ 306 M	USA
I-Mab IMAB	595	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	10.7	-	-	$ 40.3 B	USA
Genfit SA GNFT	4.22 K	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	-17.6	-	-13.47 %	$ 169 M	France
Ascendis Pharma A/S ASND	-15.7	$ 219.83	-0.92 %	$ 5 B	Danmark
Midatech Pharma plc MTP	0.796	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	-3.42	-	-1.52 %	$ 24.7 M	USA
Applied Genetic Technologies Corporation AGTC	0.546	-	-	$ 26.5 M	USA
ARCA biopharma ABIO	1.84	-	1052.0 %	$ 415 M	USA
Aeterna Zentaris AEZS	4.4	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	-1.85	-	-10.17 %	$ 12.2 K	USA
Acorda Therapeutics ACOR	0.777	-	-24.86 %	$ 820 K	USA
Albireo Pharma ALBO	-3.38	-	-0.23 %	$ 916 M	USA
Aileron Therapeutics ALRN	-0.0369	-	10.36 %	$ 9.8 M	USA
Acasti Pharma ACST	1.8	-	4.01 %	$ 150 M	Canada
Институт стволовых клеток человека ISKJ	14	-	-	-	Russia
Grifols, S.A. GRFS	13.7	$ 7.69	1.39 %	$ 6.83 B	Spain
Avenue Therapeutics ATXI	0.871	-	-52.27 %	$ 4.45 M	USA
Adverum Biotechnologies ADVM	-1.32	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	-3.39	-	2.71 %	$ 14 M	USA
Advaxis ADXS	-82.4	-	-9.65 %	$ 45.9 M	USA
CollPlant Biotechnologies Ltd. CLGN	190	$ 0.6	-2.83 %	$ 6.87 M	Israel
Ayala Pharmaceuticals AYLA	0.785	-	-	$ 7.46 M	Israel
Cullinan Management CGEM	-8.81	$ 13.01	2.12 %	$ 784 M	USA
Atreca BCEL	-2.76	-	-11.76 %	$ 5.79 M	USA
BioDelivery Sciences International BDSI	8	-	-4.8 %	$ 255 M	USA
Heron Therapeutics HRTX	-4.31	$ 0.8	2.29 %	$ 133 M	USA
BeiGene, Ltd. BGNE	-208	-	0.49 %	$ 251 B	Cayman-islands
Calithera Biosciences CALA	-7.96	-	-10.95 %	$ 876 K	USA
Cara Therapeutics CARA	-6.7	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	-0.721	-	-	$ 3.74 B	USA
Bellerophon Therapeutics BLPH	0.0235	-	-74.18 %	$ 955 K	USA
Incyte Corporation INCY	24	$ 91.13	0.38 %	$ 17.8 B	USA
Checkpoint Therapeutics CKPT	-0.833	-	-	$ 169 M	USA
Clovis Oncology CLVS	-3.86	-	-7.23 %	$ 13 M	USA
Inovio Pharmaceuticals INO	-2.19	$ 1.6	0.95 %	$ 35.5 M	USA
Aeglea BioTherapeutics AGLE	-4.27	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	-7.74	-	-	$ 867 M	Germany
Denali Therapeutics DNLI	-14.1	$ 21.15	4.86 %	$ 3.48 B	USA
Akero Therapeutics AKRO	-4.64	-	-	$ 3.67 B	USA
Inventiva S.A. IVA	-9.77	$ 6.07	5.02 %	$ 138 M	France
Arbutus Biopharma Corporation ABUS	-3.41	$ 4.3	1.3 %	$ 714 M	Canada
Akouos AKUS	-1.13	-	0.23 %	$ 488 M	USA
AIkido Pharma AIKI	-45.5	-	1.93 %	$ 17.4 M	USA
Cyclacel Pharmaceuticals CYCC	0.195	-	-5.98 %	$ 34.1 M	USA
Decibel Therapeutics DBTX	-1.91	-	-	$ 123 M	USA
Deciphera Pharmaceuticals DCPH	-1.5	-	-	$ 2.18 B	USA
Cardiff Oncology CRDF	-8.15	$ 1.8	0.08 %	$ 120 M	USA